The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats
Objective: To investigate the effect of cervical application of nonselective and selective inhibitors of nitric oxide synthases—N -nitro-L -arginine methyl ester, L -N -iminoethyl-lysine, and aminoguanidine—as well as inhibitors of cyclooxygenases—indomethacin, and nimesulide—on timing of delivery a...
Gespeichert in:
Veröffentlicht in: | American journal of obstetrics and gynecology 2001-10, Vol.185 (4), p.959-965 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 965 |
---|---|
container_issue | 4 |
container_start_page | 959 |
container_title | American journal of obstetrics and gynecology |
container_volume | 185 |
creator | Bukowski, Radoslaw McKay, Lynn Shi, Shao-Qing Saade, George R. Garfield, Robert E. |
description | Objective: To investigate the effect of cervical application of nonselective and selective inhibitors of nitric oxide synthases—N -nitro-L -arginine methyl ester, L -N -iminoethyl-lysine, and aminoguanidine—as well as inhibitors of cyclooxygenases—indomethacin, and nimesulide—on timing of delivery and fetal death and disease in pregnant rats. Study Design: In a series of experimental protocols, timed-pregnant Sprague-Dawley rats (length of pregnancy, 22 days) were randomly allocated to daily cervical applications of (1) 0.04 mg (n = 6), 0.4 mg (n = 6), 4 mg (n = 6), or 40 mg (n = 6) L -N -iminoethyl-lysine or vehicle (n = 12) on days 19 to 22 of pregnancy; (2) 50 mg aminoguanidine (n = 6), 150 mg aminoguanidine (n = 6), or vehicle (n = 10) on days 19 to 22 of pregnancy; (3) 3 mg indomethacin (n = 6) or vehicle (n = 6) on days 19 to 22 of pregnancy; (4) 12.5 mg/kg nimesulide (n = 8), 25 mg/kg nimesulide (n = 8), 50 mg/kg nimesulide (n = 12), or vehicle (n = 12) on days 19 to 22 of pregnancy and 50 mg/kg nimesulide (n = 23) or vehicle (n = 23) on days 14 to 22 of pregnancy; (5) 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine plus 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine (n = 10), or vehicle (n = 10) on days 14 to 22 of pregnancy. The following variables were evaluated: proportion of animals that were delivered on day 23, time to delivery of the first pup (midnight on day 22 was considered to be 0 hour), number of stillborn pups, and average pup weight of each litter. Results: Unlike L -N -iminoethyl-lysine, aminoguanidine, and indomethacin, 50 mg/kg nimesulide applied on the cervix daily for 8 days significantly increased the proportion of animals that were delivered on day 23 (18 of 23 versus 7 of 23; P =.003) and the time to delivery of the first pup by a mean of 10.8 hours (P |
doi_str_mv | 10.1067/mob.2001.116723 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72215979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002937801446011</els_id><sourcerecordid>72215979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-50581d3ae4e19ceb4ad0a36213cea5e3ec8c300ecc34c9ea6c50ca67e398ae813</originalsourceid><addsrcrecordid>eNp1kUtrHDEQhEVwiDdOzr4ZXZyTZ63HvHQMS-wEDL44Z6Fp9WRlZqW1NLt4_oV_cjTMgiGQU6uarwtRRcglZ2vO6uZ2F7q1YIyvOa8bIT-QFWeqKeq2bs_IijEmCiWb9px8Tul5lkKJT-Q80yWv22pF3p62SLHvEcZEQ08B49GBGajZ74f8GF3w8975revcGGJalD2A6wak3o3RAQ2vziJNkx-3JuENhQmGEF6nP-izLvgNNd7-uxU0e1sc3BHjlD1pNGP6Qj72Zkj49TQvyO-7H0-bn8XD4_2vzfeHAmQjx6JiVcutNFgiV4BdaSwzshZcApoKJUILkjEEkCUoNDVUDEzdoFStwZbLC_Jt8d3H8HLANOqdS4DDYDyGQ9KNELxSjcrg7QJCDClF7PU-up2Jk-ZMzyXoXIKeS9BLCfni6mR96HZo3_lT6hm4PgEm5az7aDy49M6VTPGqnI3UwmEO4ugw6gQOPaB1MRembXD__cRfMaSl9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72215979</pqid></control><display><type>article</type><title>The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Bukowski, Radoslaw ; McKay, Lynn ; Shi, Shao-Qing ; Saade, George R. ; Garfield, Robert E.</creator><creatorcontrib>Bukowski, Radoslaw ; McKay, Lynn ; Shi, Shao-Qing ; Saade, George R. ; Garfield, Robert E.</creatorcontrib><description>Objective: To investigate the effect of cervical application of nonselective and selective inhibitors of nitric oxide synthases—N -nitro-L -arginine methyl ester, L -N -iminoethyl-lysine, and aminoguanidine—as well as inhibitors of cyclooxygenases—indomethacin, and nimesulide—on timing of delivery and fetal death and disease in pregnant rats. Study Design: In a series of experimental protocols, timed-pregnant Sprague-Dawley rats (length of pregnancy, 22 days) were randomly allocated to daily cervical applications of (1) 0.04 mg (n = 6), 0.4 mg (n = 6), 4 mg (n = 6), or 40 mg (n = 6) L -N -iminoethyl-lysine or vehicle (n = 12) on days 19 to 22 of pregnancy; (2) 50 mg aminoguanidine (n = 6), 150 mg aminoguanidine (n = 6), or vehicle (n = 10) on days 19 to 22 of pregnancy; (3) 3 mg indomethacin (n = 6) or vehicle (n = 6) on days 19 to 22 of pregnancy; (4) 12.5 mg/kg nimesulide (n = 8), 25 mg/kg nimesulide (n = 8), 50 mg/kg nimesulide (n = 12), or vehicle (n = 12) on days 19 to 22 of pregnancy and 50 mg/kg nimesulide (n = 23) or vehicle (n = 23) on days 14 to 22 of pregnancy; (5) 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine plus 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine (n = 10), or vehicle (n = 10) on days 14 to 22 of pregnancy. The following variables were evaluated: proportion of animals that were delivered on day 23, time to delivery of the first pup (midnight on day 22 was considered to be 0 hour), number of stillborn pups, and average pup weight of each litter. Results: Unlike L -N -iminoethyl-lysine, aminoguanidine, and indomethacin, 50 mg/kg nimesulide applied on the cervix daily for 8 days significantly increased the proportion of animals that were delivered on day 23 (18 of 23 versus 7 of 23; P =.003) and the time to delivery of the first pup by a mean of 10.8 hours (P <.001). Shorter treatment with nimesulide for 4 days increased only the time to delivery of the first pup at the 25-mg/kg dosage (P =.008). Simultaneous application of aminoguanidine and nimesulide significantly (P =.008) prolonged pregnancy to a degree similar to nimesulide alone. The experiment with N -nitro-L -arginine methyl ester was aborted because of severe maternal side effects. Unlike pups in the L -N -iminoethyl-lysine, aminoguanidine, and nimesulide groups, significantly more pups in the indomethacin group died in utero compared with the control group (36.1% versus 3.1%; P <.001), and the surviving pups had lower birth weights (P <.001). Conclusions: In an animal model, nimesulide was effective in delaying the onset of labor, was well tolerated during pregnancy, and affected cervical ripening directly independent of progesterone withdrawal. Conversely, cervical application of nitric oxide synthase and nonselective cyclooxygenase inhibitors do not extend the duration of pregnancy in the dosages studied, and some are associated with significant adverse effects in the mothers and fetuses. (Am J Obstet Gynecol 2001;185: 959-65.)</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1067/mob.2001.116723</identifier><identifier>PMID: 11641685</identifier><identifier>CODEN: AJOGAH</identifier><language>eng</language><publisher>Philadelphia, PA: Mosby, Inc</publisher><subject>Administration, Topical ; Animals ; Biological and medical sciences ; cervical ripening ; Cervical Ripening - drug effects ; Cervix Uteri - drug effects ; Cervix Uteri - physiology ; cyclooxygenase inhibitor ; Cyclooxygenase Inhibitors - pharmacology ; Delivery, Obstetric - methods ; Female ; Fetal Death ; Genital system. Reproduction ; Guanidines - pharmacology ; Indomethacin - pharmacology ; Inhibition ; Medical sciences ; Models, Animal ; NG-Nitroarginine Methyl Ester - administration & dosage ; nitric oxide synthase inhibitor ; Pharmacology. Drug treatments ; Pregnancy ; Pregnancy Outcome ; Pregnancy, Animal ; preterm delivery ; Probability ; Rats ; Rats, Sprague-Dawley ; Sensitivity and Specificity ; Statistics, Nonparametric ; Sulfonamides - pharmacology ; Treatment Outcome</subject><ispartof>American journal of obstetrics and gynecology, 2001-10, Vol.185 (4), p.959-965</ispartof><rights>2001 Mosby, Inc.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-50581d3ae4e19ceb4ad0a36213cea5e3ec8c300ecc34c9ea6c50ca67e398ae813</citedby><cites>FETCH-LOGICAL-c373t-50581d3ae4e19ceb4ad0a36213cea5e3ec8c300ecc34c9ea6c50ca67e398ae813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1067/mob.2001.116723$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3548,23929,23930,25139,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14091543$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11641685$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bukowski, Radoslaw</creatorcontrib><creatorcontrib>McKay, Lynn</creatorcontrib><creatorcontrib>Shi, Shao-Qing</creatorcontrib><creatorcontrib>Saade, George R.</creatorcontrib><creatorcontrib>Garfield, Robert E.</creatorcontrib><title>The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Objective: To investigate the effect of cervical application of nonselective and selective inhibitors of nitric oxide synthases—N -nitro-L -arginine methyl ester, L -N -iminoethyl-lysine, and aminoguanidine—as well as inhibitors of cyclooxygenases—indomethacin, and nimesulide—on timing of delivery and fetal death and disease in pregnant rats. Study Design: In a series of experimental protocols, timed-pregnant Sprague-Dawley rats (length of pregnancy, 22 days) were randomly allocated to daily cervical applications of (1) 0.04 mg (n = 6), 0.4 mg (n = 6), 4 mg (n = 6), or 40 mg (n = 6) L -N -iminoethyl-lysine or vehicle (n = 12) on days 19 to 22 of pregnancy; (2) 50 mg aminoguanidine (n = 6), 150 mg aminoguanidine (n = 6), or vehicle (n = 10) on days 19 to 22 of pregnancy; (3) 3 mg indomethacin (n = 6) or vehicle (n = 6) on days 19 to 22 of pregnancy; (4) 12.5 mg/kg nimesulide (n = 8), 25 mg/kg nimesulide (n = 8), 50 mg/kg nimesulide (n = 12), or vehicle (n = 12) on days 19 to 22 of pregnancy and 50 mg/kg nimesulide (n = 23) or vehicle (n = 23) on days 14 to 22 of pregnancy; (5) 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine plus 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine (n = 10), or vehicle (n = 10) on days 14 to 22 of pregnancy. The following variables were evaluated: proportion of animals that were delivered on day 23, time to delivery of the first pup (midnight on day 22 was considered to be 0 hour), number of stillborn pups, and average pup weight of each litter. Results: Unlike L -N -iminoethyl-lysine, aminoguanidine, and indomethacin, 50 mg/kg nimesulide applied on the cervix daily for 8 days significantly increased the proportion of animals that were delivered on day 23 (18 of 23 versus 7 of 23; P =.003) and the time to delivery of the first pup by a mean of 10.8 hours (P <.001). Shorter treatment with nimesulide for 4 days increased only the time to delivery of the first pup at the 25-mg/kg dosage (P =.008). Simultaneous application of aminoguanidine and nimesulide significantly (P =.008) prolonged pregnancy to a degree similar to nimesulide alone. The experiment with N -nitro-L -arginine methyl ester was aborted because of severe maternal side effects. Unlike pups in the L -N -iminoethyl-lysine, aminoguanidine, and nimesulide groups, significantly more pups in the indomethacin group died in utero compared with the control group (36.1% versus 3.1%; P <.001), and the surviving pups had lower birth weights (P <.001). Conclusions: In an animal model, nimesulide was effective in delaying the onset of labor, was well tolerated during pregnancy, and affected cervical ripening directly independent of progesterone withdrawal. Conversely, cervical application of nitric oxide synthase and nonselective cyclooxygenase inhibitors do not extend the duration of pregnancy in the dosages studied, and some are associated with significant adverse effects in the mothers and fetuses. (Am J Obstet Gynecol 2001;185: 959-65.)</description><subject>Administration, Topical</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>cervical ripening</subject><subject>Cervical Ripening - drug effects</subject><subject>Cervix Uteri - drug effects</subject><subject>Cervix Uteri - physiology</subject><subject>cyclooxygenase inhibitor</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>Delivery, Obstetric - methods</subject><subject>Female</subject><subject>Fetal Death</subject><subject>Genital system. Reproduction</subject><subject>Guanidines - pharmacology</subject><subject>Indomethacin - pharmacology</subject><subject>Inhibition</subject><subject>Medical sciences</subject><subject>Models, Animal</subject><subject>NG-Nitroarginine Methyl Ester - administration & dosage</subject><subject>nitric oxide synthase inhibitor</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome</subject><subject>Pregnancy, Animal</subject><subject>preterm delivery</subject><subject>Probability</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sensitivity and Specificity</subject><subject>Statistics, Nonparametric</subject><subject>Sulfonamides - pharmacology</subject><subject>Treatment Outcome</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtrHDEQhEVwiDdOzr4ZXZyTZ63HvHQMS-wEDL44Z6Fp9WRlZqW1NLt4_oV_cjTMgiGQU6uarwtRRcglZ2vO6uZ2F7q1YIyvOa8bIT-QFWeqKeq2bs_IijEmCiWb9px8Tul5lkKJT-Q80yWv22pF3p62SLHvEcZEQ08B49GBGajZ74f8GF3w8975revcGGJalD2A6wak3o3RAQ2vziJNkx-3JuENhQmGEF6nP-izLvgNNd7-uxU0e1sc3BHjlD1pNGP6Qj72Zkj49TQvyO-7H0-bn8XD4_2vzfeHAmQjx6JiVcutNFgiV4BdaSwzshZcApoKJUILkjEEkCUoNDVUDEzdoFStwZbLC_Jt8d3H8HLANOqdS4DDYDyGQ9KNELxSjcrg7QJCDClF7PU-up2Jk-ZMzyXoXIKeS9BLCfni6mR96HZo3_lT6hm4PgEm5az7aDy49M6VTPGqnI3UwmEO4ugw6gQOPaB1MRembXD__cRfMaSl9A</recordid><startdate>20011001</startdate><enddate>20011001</enddate><creator>Bukowski, Radoslaw</creator><creator>McKay, Lynn</creator><creator>Shi, Shao-Qing</creator><creator>Saade, George R.</creator><creator>Garfield, Robert E.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20011001</creationdate><title>The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats</title><author>Bukowski, Radoslaw ; McKay, Lynn ; Shi, Shao-Qing ; Saade, George R. ; Garfield, Robert E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-50581d3ae4e19ceb4ad0a36213cea5e3ec8c300ecc34c9ea6c50ca67e398ae813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Administration, Topical</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>cervical ripening</topic><topic>Cervical Ripening - drug effects</topic><topic>Cervix Uteri - drug effects</topic><topic>Cervix Uteri - physiology</topic><topic>cyclooxygenase inhibitor</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>Delivery, Obstetric - methods</topic><topic>Female</topic><topic>Fetal Death</topic><topic>Genital system. Reproduction</topic><topic>Guanidines - pharmacology</topic><topic>Indomethacin - pharmacology</topic><topic>Inhibition</topic><topic>Medical sciences</topic><topic>Models, Animal</topic><topic>NG-Nitroarginine Methyl Ester - administration & dosage</topic><topic>nitric oxide synthase inhibitor</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome</topic><topic>Pregnancy, Animal</topic><topic>preterm delivery</topic><topic>Probability</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sensitivity and Specificity</topic><topic>Statistics, Nonparametric</topic><topic>Sulfonamides - pharmacology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bukowski, Radoslaw</creatorcontrib><creatorcontrib>McKay, Lynn</creatorcontrib><creatorcontrib>Shi, Shao-Qing</creatorcontrib><creatorcontrib>Saade, George R.</creatorcontrib><creatorcontrib>Garfield, Robert E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bukowski, Radoslaw</au><au>McKay, Lynn</au><au>Shi, Shao-Qing</au><au>Saade, George R.</au><au>Garfield, Robert E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2001-10-01</date><risdate>2001</risdate><volume>185</volume><issue>4</issue><spage>959</spage><epage>965</epage><pages>959-965</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><coden>AJOGAH</coden><abstract>Objective: To investigate the effect of cervical application of nonselective and selective inhibitors of nitric oxide synthases—N -nitro-L -arginine methyl ester, L -N -iminoethyl-lysine, and aminoguanidine—as well as inhibitors of cyclooxygenases—indomethacin, and nimesulide—on timing of delivery and fetal death and disease in pregnant rats. Study Design: In a series of experimental protocols, timed-pregnant Sprague-Dawley rats (length of pregnancy, 22 days) were randomly allocated to daily cervical applications of (1) 0.04 mg (n = 6), 0.4 mg (n = 6), 4 mg (n = 6), or 40 mg (n = 6) L -N -iminoethyl-lysine or vehicle (n = 12) on days 19 to 22 of pregnancy; (2) 50 mg aminoguanidine (n = 6), 150 mg aminoguanidine (n = 6), or vehicle (n = 10) on days 19 to 22 of pregnancy; (3) 3 mg indomethacin (n = 6) or vehicle (n = 6) on days 19 to 22 of pregnancy; (4) 12.5 mg/kg nimesulide (n = 8), 25 mg/kg nimesulide (n = 8), 50 mg/kg nimesulide (n = 12), or vehicle (n = 12) on days 19 to 22 of pregnancy and 50 mg/kg nimesulide (n = 23) or vehicle (n = 23) on days 14 to 22 of pregnancy; (5) 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine plus 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine (n = 10), or vehicle (n = 10) on days 14 to 22 of pregnancy. The following variables were evaluated: proportion of animals that were delivered on day 23, time to delivery of the first pup (midnight on day 22 was considered to be 0 hour), number of stillborn pups, and average pup weight of each litter. Results: Unlike L -N -iminoethyl-lysine, aminoguanidine, and indomethacin, 50 mg/kg nimesulide applied on the cervix daily for 8 days significantly increased the proportion of animals that were delivered on day 23 (18 of 23 versus 7 of 23; P =.003) and the time to delivery of the first pup by a mean of 10.8 hours (P <.001). Shorter treatment with nimesulide for 4 days increased only the time to delivery of the first pup at the 25-mg/kg dosage (P =.008). Simultaneous application of aminoguanidine and nimesulide significantly (P =.008) prolonged pregnancy to a degree similar to nimesulide alone. The experiment with N -nitro-L -arginine methyl ester was aborted because of severe maternal side effects. Unlike pups in the L -N -iminoethyl-lysine, aminoguanidine, and nimesulide groups, significantly more pups in the indomethacin group died in utero compared with the control group (36.1% versus 3.1%; P <.001), and the surviving pups had lower birth weights (P <.001). Conclusions: In an animal model, nimesulide was effective in delaying the onset of labor, was well tolerated during pregnancy, and affected cervical ripening directly independent of progesterone withdrawal. Conversely, cervical application of nitric oxide synthase and nonselective cyclooxygenase inhibitors do not extend the duration of pregnancy in the dosages studied, and some are associated with significant adverse effects in the mothers and fetuses. (Am J Obstet Gynecol 2001;185: 959-65.)</abstract><cop>Philadelphia, PA</cop><pub>Mosby, Inc</pub><pmid>11641685</pmid><doi>10.1067/mob.2001.116723</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9378 |
ispartof | American journal of obstetrics and gynecology, 2001-10, Vol.185 (4), p.959-965 |
issn | 0002-9378 1097-6868 |
language | eng |
recordid | cdi_proquest_miscellaneous_72215979 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Administration, Topical Animals Biological and medical sciences cervical ripening Cervical Ripening - drug effects Cervix Uteri - drug effects Cervix Uteri - physiology cyclooxygenase inhibitor Cyclooxygenase Inhibitors - pharmacology Delivery, Obstetric - methods Female Fetal Death Genital system. Reproduction Guanidines - pharmacology Indomethacin - pharmacology Inhibition Medical sciences Models, Animal NG-Nitroarginine Methyl Ester - administration & dosage nitric oxide synthase inhibitor Pharmacology. Drug treatments Pregnancy Pregnancy Outcome Pregnancy, Animal preterm delivery Probability Rats Rats, Sprague-Dawley Sensitivity and Specificity Statistics, Nonparametric Sulfonamides - pharmacology Treatment Outcome |
title | The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T18%3A32%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20cervical%20application%20of%20inhibitors%20of%20inducible%20nitric%20oxide%20synthase,%20cyclooxygenase-1,%20and%20cyclooxygenase-2%20on%20delivery%20in%20rats&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Bukowski,%20Radoslaw&rft.date=2001-10-01&rft.volume=185&rft.issue=4&rft.spage=959&rft.epage=965&rft.pages=959-965&rft.issn=0002-9378&rft.eissn=1097-6868&rft.coden=AJOGAH&rft_id=info:doi/10.1067/mob.2001.116723&rft_dat=%3Cproquest_cross%3E72215979%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72215979&rft_id=info:pmid/11641685&rft_els_id=S0002937801446011&rfr_iscdi=true |